Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer

Daniel H. Ahn, Junan Li, Lai Wei, Austin Doyle, John L. Marshall, Larry J. Schaaf, Mitch A. Phelps, Miguel A. Villalona-Calero, Tanios Bekaii-Saab

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences